1-4 of 4
Ana Cristina Tejada Vasquez
Close
Sort by
Journal Articles

CYP Inhibition and Low-Dose Dasatinib for Chronic Myeloid Leukemia: Preliminary Results of a Promising, Cost-Effective Treatment Option

Juan Francisco Barrios Ruiz, Fernando De La Garza, Victor Mingura Ledezma, Olga Cantu, Ana Cristina Tejada Vasquez, David Gomez-Almaguer, Perla R. Rocio Colunga-Pedraza
Journal: Blood
Blood (2023) 142 (Supplement 1): 5744.
https://doi.org/10.1182/blood-2023-188215
Published: 2023
Journal Articles

Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting

Yadith Karina Lopez-Garcia, Fernando De La Garza, Gerardo Alexis De la Rosa-Flores, Edgar Ulises Coronado Alejandro, Antonio Vega-Mateos, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Valeria García-Zárate, Perla R. Rocio Colunga-Pedraza, David Gomez-Almaguer, Andres Gomez-De Leon
Journal: Blood
Blood (2023) 142 (Supplement 1): 1529.
https://doi.org/10.1182/blood-2023-188088
Published: 2023
Journal Articles

Lost and Found: A Mixed Methods Study on Treatment Abandonment in Acute Leukemia

Ana Cristina Tejada Vasquez, Eliezer Gomez, Fernando De La Garza, Edgar Ulises Coronado Alejandro, Carlos De La Cruz-De La Cruz, Valeria García-Zárate, Anna Cecilia Rodriguez-Zuñiga, Alexia Sánchez, David Gomez-Almaguer, Andres Gomez-De Leon
Journal: Blood
Blood (2023) 142 (Supplement 1): 2439.
https://doi.org/10.1182/blood-2023-189645
Published: 2023
Journal Articles

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Héctor Alejandro Vaquera Alfaro, Zulia Guzman-Martínez, Antonio Vega-Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, César Homero Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza
Journal: Blood
Blood (2023) 142 (Supplement 1): 1711.
https://doi.org/10.1182/blood-2023-188171
Published: 2023